Search research articles
Contact Us
Filters
Showing results (201-210 of 213) with videos related to
Page
of 22
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
April 20, 2021
Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5'-deoxy-5-fluorocytidine (5'-DFCR)
Yanyun Gao, Philipp Zens, Min Su, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
July 30, 2020
EpCAM<sup>+</sup>CD73<sup>+</sup> mark epithelial progenitor cells in postnatal human lung and are associated with pathogenesis of pulmonary disease including lung adenocarcinoma
Limei Wang, Patrick Dorn, Cedric Simillion, et al.
British Journal of Cancer
|
September 3, 2010
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
T-S Yang, S-N Lu, Y Chao, et al.
Clinical and Translational Medicine
|
March 31, 2025
Transitional CXCL14<sup>+</sup> cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma
Weijiao Xu, Haitang Yang, Ke Xu, et al.
EMBO Molecular Medicine
|
August 9, 2021
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancer
Zhang Yang, Shun-Qing Liang, Maria Saliakoura, et al.
Oncogene
|
September 2, 2018
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer
Shun-Qing Liang, Elias D Bührer, Sabina Berezowska, et al.
Cell Death Discovery
|
February 10, 2023
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma
Haitang Yang, Yanyun Gao, Duo Xu, et al.
Neoplasia (New York, N.Y.)
|
December 29, 2018
Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549
Colin Charles Tièche, Yanyun Gao, Elias Daniel Bührer, et al.
Cellular and Molecular Life Sciences : CMLS
|
July 25, 2022
Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage
Haibin Deng, Yanyun Gao, Verdiana Trappetti, et al.
Journal for Immunotherapy of Cancer
|
June 11, 2025
Low-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor control
Louis-Emmanuel Chriqui, Damien Nicolas Marie, Alexandros Sifis, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 213) with videos related to
Sort By:
Page
of 22
Journal of Experimental & Clinical Cancer Research : CR
|
April 20, 2021
Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5'-deoxy-5-fluorocytidine (5'-DFCR)
Yanyun Gao, Philipp Zens, Min Su, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
July 30, 2020
EpCAM<sup>+</sup>CD73<sup>+</sup> mark epithelial progenitor cells in postnatal human lung and are associated with pathogenesis of pulmonary disease including lung adenocarcinoma
Limei Wang, Patrick Dorn, Cedric Simillion, et al.
British Journal of Cancer
|
September 3, 2010
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
T-S Yang, S-N Lu, Y Chao, et al.
Clinical and Translational Medicine
|
March 31, 2025
Transitional CXCL14<sup>+</sup> cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma
Weijiao Xu, Haitang Yang, Ke Xu, et al.
EMBO Molecular Medicine
|
August 9, 2021
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancer
Zhang Yang, Shun-Qing Liang, Maria Saliakoura, et al.
Oncogene
|
September 2, 2018
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer
Shun-Qing Liang, Elias D Bührer, Sabina Berezowska, et al.
Cell Death Discovery
|
February 10, 2023
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma
Haitang Yang, Yanyun Gao, Duo Xu, et al.
Neoplasia (New York, N.Y.)
|
December 29, 2018
Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549
Colin Charles Tièche, Yanyun Gao, Elias Daniel Bührer, et al.
Cellular and Molecular Life Sciences : CMLS
|
July 25, 2022
Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage
Haibin Deng, Yanyun Gao, Verdiana Trappetti, et al.
Journal for Immunotherapy of Cancer
|
June 11, 2025
Low-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor control
Louis-Emmanuel Chriqui, Damien Nicolas Marie, Alexandros Sifis, et al.
Page
of 22